Juva Life Inc. Share Price Other OTC
Equities
JUVAF
CA48222R1010
Pharmaceuticals
Sales 2021 | 3.87 308.02 | Sales 2022 | 5.76 459.04 | Capitalization | 10.4M 828M |
---|---|---|---|---|---|
Net income 2021 | -11M -876M | Net income 2022 | -10M -796M | EV / Sales 2021 | 8,085,207 x |
Net Debt 2021 | 1.62M 129M | Net Debt 2022 | 7.38M 588M | EV / Sales 2022 | 3,084,662 x |
P/E ratio 2021 |
-2.51
x | P/E ratio 2022 |
-0.99
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 52.48% |
Managers | Title | Age | Since |
---|---|---|---|
Douglas Chloupek
CEO | Chief Executive Officer | - | - |
Mathew Lee
DFI | Director of Finance/CFO | 40 | 02/04/19 |
Dan Hughes
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Kari A. Gothie
ADM | Chief Administrative Officer | - | 29/05/19 |
Mathew Lee
DFI | Director of Finance/CFO | 40 | 02/04/19 |
Douglas Chloupek
CEO | Chief Executive Officer | - | - |
1st Jan change | Capi. | |
---|---|---|
+35.93% | 4.09B | |
+131.24% | 2.18B | |
+134.92% | 76.48M |